News
Looking Into Biomarin Pharmaceutical's Recent Short Interest
3 Apr 24
Short Sellers, Short Ideas, Trading Ideas
New Data To Be Presented For BioMarin's VOXZOGO In Children With Hypochondroplasia And Achondroplasia At The American College Of Medical Genetics And Genomics Annual Clinical Genetics Meeting
12 Mar 24
Biotech, News, Events, General
Canaccord Genuity Reiterates Hold on Biomarin Pharmaceutical, Maintains $91 Price Target
29 Feb 24
News, Price Target, Reiteration, Analyst Ratings
BioMarin Complied With A U.S. Department Of Justice Subpoena For Documents On Its Testing Programs For VIMIZIM And NAGLAZYME; Cannot Predict Investigation's Outcome Or Its Impact On Its Business Or Financial Statements
26 Feb 24
News, Legal
The Latest Analyst Ratings For Biomarin Pharmaceutical
23 Feb 24
Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Biomarin Pharmaceutical, Maintains $100 Price Target
23 Feb 24
News, Price Target, Reiteration, Analyst Ratings
RBC Capital Reiterates Sector Perform on Biomarin Pharmaceutical, Maintains $100 Price Target
23 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Recap: Biomarin Pharmaceutical Q4 Earnings
22 Feb 24
Earnings
Biomarin Pharmaceutical Q4 2023 Adj EPS $0.49 Beats $0.23 Estimate, Sales $646.20M Beat $636.88M Estimate
22 Feb 24
Earnings, Earnings Beats, News
Earnings Scheduled For February 22, 2024
22 Feb 24
Earnings
BioMarin To Present ROCTAVIAN Data Highlighting Long-Term Durability At 2024 European Association For Haemophilia And Allied Disorders Congress
6 Feb 24
Biotech, News, General
Decoding 8 Analyst Evaluations For Biomarin Pharmaceutical
30 Jan 24
Analyst Ratings
Baird Maintains Outperform on Biomarin Pharmaceutical, Lowers Price Target to $104
30 Jan 24
News, Price Target, Analyst Ratings
Press releases
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET
10 Apr 24
Press Releases
New Data to be Presented for BioMarin's VOXZOGO® (vosoritide) in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
12 Mar 24
Press Releases
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
7 Mar 24
Press Releases
BioMarin Scheduled to Participate in March Investor Conferences
1 Mar 24
Press Releases
NorthStar Medical Technologies, LLC Announces Appointment of Barbara Bodem and David Keeling to Board of Managers
27 Feb 24
Press Releases
BioMarin to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Thursday, February 22, 2024, at 4:30pm ET
8 Feb 24
Press Releases
BioMarin to Present ROCTAVIAN™ (valoctocogene roxaparvovec-rvox) Data Highlighting Long-Term Durability at 2024 European Association for Haemophilia and Allied Disorders (EAHAD) Congress
6 Feb 24
Press Releases